Envestnet Asset Management Inc Biotechnology

Envestnet Asset Management Inc

$302 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
DNLI Denali Therapeutics Inc.	$2.98B	$815,000 0.0% of portfolio	27,979	Q3 2024 Added 32.34%
ADMA Adma Biologics, Inc.	$3.16B	$713,000 0.0% of portfolio	35,711	Q3 2024 Added 172.27%
BEAM Beam Therapeutics Inc.	$1.83B	$690,000 0.0% of portfolio	28,171	Q3 2024 Added 37.17%
CDXS Codexis, Inc.	$322M	$613,000 0.0% of portfolio	199,172	Q3 2024 Reduced 7.91%
OLMA Olema Pharmaceuticals, Inc.	$243M	$594,000 0.0% of portfolio	49,786	Q3 2024 Added 1.15%
RCKT Rocket Pharmaceuticals, Inc.	$811M	$575,000 0.0% of portfolio	31,142	Q3 2024 Added 4.53%
PTGX Protagonist Therapeutics, Inc	$1.85B	$574,000 0.0% of portfolio	12,783	Q3 2024 Reduced 5.72%
CPRX Catalyst Pharmaceuticals, Inc.	$2.32B	$488,000 0.0% of portfolio	24,559	Q3 2024 Reduced 21.98%
TARS Tarsus Pharmaceuticals, Inc.	$1.31B	$474,000 0.0% of portfolio	14,415	Q3 2024 Added 36.8%
MLTX Moon Lake Immunotherapeutics	$1.69B	$462,000 0.0% of portfolio	9,164	Q3 2024 Added 12.5%
RVMD Revolution Medicines, Inc.	$3.59B	$425,000 0.0% of portfolio	9,384	Q3 2024 New
BBIO Bridge Bio Pharma, Inc.	$5.57B	$404,000 0.0% of portfolio	15,875	Q3 2024 Reduced 40.52%
ABSI Absci Corp	$391M	$359,000 0.0% of portfolio	94,025	Q3 2024 Added 24.96%
MRVI Maravai Lifesciences Holdings, Inc.	$739M	$354,000 0.0% of portfolio	42,693	Q3 2024 Reduced 15.01%
INVA Innoviva, Inc.	$1.3B	$337,000 0.0% of portfolio	17,495	Q3 2024 Added 16.53%
ACLX Arcellx, Inc.	$2.76B	$312,000 0.0% of portfolio	3,746	Q3 2024 New
AKRO Akero Therapeutics, Inc.	$1.21B	$307,000 0.0% of portfolio	10,708	Q3 2024 New
EWTX Edgewise Therapeutics, Inc.	$1.79B	$296,000 0.0% of portfolio	11,117	Q3 2024 New
SAVA Cassava Sciences Inc	$101M	$290,000 0.0% of portfolio	9,887	Q3 2024 New
IOVA Iovance Biotherapeutics, Inc.	$986M	$275,000 0.0% of portfolio	29,377	Q3 2024 Added 13.9%
MRUS Merus N.V.	$1.89B	$259,000 0.0% of portfolio	5,188	Q3 2024 New
VERU Veru Inc.	$97M	$254,000 0.0% of portfolio	330,758	Q3 2024 Reduced 2.42%
CABA Cabaletta Bio, Inc.	$72.5M	$226,000 0.0% of portfolio	48,070	Q3 2024 Added 60.09%
AVXL Anavex Life Sciences Corp.	$818M	$217,000 0.0% of portfolio	38,295	Q3 2024 New
LRMR Larimar Therapeutics, Inc.	$155M	$207,000 0.0% of portfolio	31,648	Q3 2024 Added 22.11%
WVE Wave Life Sciences Ltd.	$1.04B	$160,000 0.0% of portfolio	19,607	Q3 2024 Added 25.91%
BLRX Bio Line Rx Ltd.	$6.77M	$129,000 0.0% of portfolio	239,186	Q3 2024 Added 11.86%
VNDA Vanda Pharmaceuticals Inc.	$249M	$119,000 0.0% of portfolio	25,496	Q3 2024 Added 5.85%
ALT Altimmune, Inc.	$342M	$117,000 0.0% of portfolio	19,084	Q3 2024 Reduced 31.39%
CDMO Avid Bioservices, Inc.	$772M	$117,000 0.0% of portfolio	10,350	Q3 2024 New
MIST Milestone Pharmaceuticals Inc.	$62.1M	$107,000 0.0% of portfolio	70,590	Q3 2024 Added 18.59%
SRRK Scholar Rock Holding Corp	$2.27B	$85,000 0.0% of portfolio	10,614	Q3 2024 Added 6.14%
MNKD Mannkind Corp	$1.55B	$65,000 0.0% of portfolio	10,504	Q3 2024 New
CRBU Caribou Biosciences, Inc.	$91.9M	$62,000 0.0% of portfolio	32,280	Q3 2024 Reduced 2.62%
ABCL Ab Cellera Biologics Inc.	$992M	$60,000 0.0% of portfolio	23,209	Q3 2024 Added 54.74%
HRTX Heron Therapeutics, Inc.	$210M	$55,000 0.0% of portfolio	27,840	Q3 2024 Added 45.33%
ALLO Allogene Therapeutics, Inc.	$279M	$43,000 0.0% of portfolio	15,599	Q3 2024 Added 11.73%
CDXC Chroma Dex Corp.	$414M	$36,000 0.0% of portfolio	10,000	Q3 2023 Reduced 37.52%
CGEN Compugen LTD	$207M	$34,000 0.0% of portfolio	19,327	Q3 2024 Reduced 11.38%
PGEN Precigen, Inc.	$264M	$19,000 0.0% of portfolio	20,428	Q3 2024 Added 18.88%
TLSA Tiziana Life Sciences LTD	$80.8M	$14,000 0.0% of portfolio	14,622	Q2 2024 Reduced 12.95%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.